| Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method A Breier, TP Su, R Saunders, RE Carson, BS Kolachana, ... Proceedings of the National Academy of Sciences 94 (6), 2569-2574, 1997 | 1344 | 1997 |
| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 409 | 2017 |
| Simian virus-40 large-T antigen binds p53 in human mesotheliomas M Carbone, P Rizzo, PM Grimley, A Procopio, DJY Mew, V Shridhar, ... Nature medicine 3 (8), 908-912, 1997 | 313 | 1997 |
| Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous Infusion RE Carson, A Breier, A De Bartolomeis, RC Saunders, TP Su, B Schmall, ... Journal of Cerebral Blood Flow & Metabolism 17 (4), 437-447, 1997 | 255 | 1997 |
| Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis V De Luca, DJ Mueller, A de Bartolomeis, JL Kennedy International Journal of Neuropsychopharmacology 10 (5), 697-704, 2007 | 135 | 2007 |
| Update on the mechanism of action of aripiprazole: translational insights into antipsychotic strategies beyond dopamine receptor antagonism A De Bartolomeis, C Tomasetti, F Iasevoli CNS drugs 29 (9), 773-799, 2015 | 123 | 2015 |
| Increased signaling via adenosine A1 receptors, sleep deprivation, imipramine, and ketamine inhibit depressive-like behavior via induction of Homer1a T Serchov, HW Clement, MK Schwarz, F Iasevoli, DK Tosh, M Idzko, ... Neuron 87 (3), 549-562, 2015 | 118 | 2015 |
| Permanent Focal Brain Ischemia Induces Isoform-Dependent Changes in the Pattern of Na+/Ca2+ Exchanger Gene Expression in the Ischemic Core, Periinfarct … F Boscia, R Gala, G Pignataro, A De Bartolomeis, M Cicale, ... Journal of Cerebral Blood Flow & Metabolism 26 (4), 502-517, 2006 | 99 | 2006 |
| The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy. A de Bartolomeis, F Iasevoli Psychopharmacology bulletin 37 (3), 51-83, 2003 | 97 | 2003 |
| Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice F Guida, L Luongo, F Marmo, R Romano, M Iannotta, F Napolitano, ... Molecular brain 8 (1), 1-15, 2015 | 96 | 2015 |
| Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant … F Iasevoli, S Giordano, R Balletta, G Latte, MV Formato, E Prinzivalli, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 65, 34-48, 2016 | 92 | 2016 |
| An update of safety of clinically used atypical antipsychotics L Orsolini, C Tomasetti, A Valchera, R Vecchiotti, I Matarazzo, F Vellante, ... Expert opinion on drug safety 15 (10), 1329-1347, 2016 | 91 | 2016 |
| Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders … A de Bartolomeis, G Latte, C Tomasetti, F Iasevoli Molecular neurobiology 49 (1), 484-511, 2014 | 91 | 2014 |
| Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic … A De Bartolomeis, EF Buonaguro, F Iasevoli Psychopharmacology 225 (1), 1-19, 2013 | 83 | 2013 |
| Targeting glutamate system for novel antipsychotic approaches: relevance for residual psychotic symptoms and treatment resistant schizophrenia A de Bartolomeis, C Sarappa, S Magara, F Iasevoli European journal of pharmacology 682 (1-3), 1-11, 2012 | 76 | 2012 |
| Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia F Errico, F Napolitano, M Squillace, D Vitucci, G Blasi, A de Bartolomeis, ... Journal of psychiatric research 47 (10), 1432-1437, 2013 | 71 | 2013 |
| Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis A De Bartolomeis, G Fiore, F Iasevoli Current pharmaceutical design 11 (27), 3561-3594, 2005 | 67 | 2005 |
| Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine D Polese, AA de Serpis, A Ambesi-Impiombato, G Muscettola, ... Neuropsychopharmacology 27 (6), 906-913, 2002 | 67 | 2002 |
| Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder G D’Urso, AR Brunoni, A Anastasia, M Micillo, A de Bartolomeis, ... Neurocase 22 (1), 60-64, 2016 | 65 | 2016 |
| Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to … A de Bartolomeis, R Balletta, S Giordano, EF Buonaguro, G Latte, ... Psychiatry research 210 (2), 387-395, 2013 | 65 | 2013 |
Elisabetta Filomena BuonaguroDpt Neuroscienze, Facoltà di Medicina Federico II, NapoliVerified email at studenti.unina.it
